testing all

Nanomedicine (Record no. 10501)

MARC details
000 -LEADER
fixed length control field 02276 a2200397 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250526161931.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 250430042023xx 4 eng
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9781032435435
Qualifying information BB
037 ## - SOURCE OF ACQUISITION
Source of stock number/acquisition Taylor & Francis
Terms of availability GBP 210.00
Form of issue BB
040 ## - CATALOGING SOURCE
Original cataloging agency 01
041 ## - LANGUAGE CODE
Language code of text/sound track or separate title eng
072 7# - SUBJECT CATEGORY CODE
Subject category code TBN
Source thema
072 7# - SUBJECT CATEGORY CODE
Subject category code TCB
Source thema
072 7# - SUBJECT CATEGORY CODE
Subject category code PS
Source thema
072 7# - SUBJECT CATEGORY CODE
Subject category code MKG
Source thema
072 7# - SUBJECT CATEGORY CODE
Subject category code TBN
Source bic
072 7# - SUBJECT CATEGORY CODE
Subject category code TCB
Source bic
072 7# - SUBJECT CATEGORY CODE
Subject category code PS
Source bic
072 7# - SUBJECT CATEGORY CODE
Subject category code MMG
Source bic
072 7# - SUBJECT CATEGORY CODE
Subject category code SCI050000
Source bisac
072 7# - SUBJECT CATEGORY CODE
Subject category code SCI009000
Source bisac
072 7# - SUBJECT CATEGORY CODE
Subject category code SCI075000
Source bisac
072 7# - SUBJECT CATEGORY CODE
Subject category code MED009000
Source bisac
072 7# - SUBJECT CATEGORY CODE
Subject category code MED071000
Source bisac
072 7# - SUBJECT CATEGORY CODE
Subject category code SCI010000
Source bisac
072 7# - SUBJECT CATEGORY CODE
Subject category code SCI086000
Source bisac
072 7# - SUBJECT CATEGORY CODE
Subject category code TEC027000
Source bisac
072 7# - SUBJECT CATEGORY CODE
Subject category code 610.28
Source bisac
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Jonathan Simon
9 (RLIN) 778
245 10 - TITLE STATEMENT
Title Nanomedicine
Remainder of title Panacea or Pandora's Box?
250 ## - EDITION STATEMENT
Edition statement 1
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. CRC Press
Date of publication, distribution, etc. 20230425
300 ## - PHYSICAL DESCRIPTION
Extent 163 p
520 ## - SUMMARY, ETC.
Expansion of summary note The book is an introduction to nanomedicine informed by a philosophical reflection about the domain and recent developments. It is an overview of the field, sketching out the main areas of current investment and research. The authors present some case-studies illustrating the different areas of research (nanopharmacy, theranostics and patient monitoring) as well as reflecting on the risks that accompany it, such as unanticipated impacts on human health and environmental toxicity. This introduction to a fast-growing field in modern medical research is of great interest to researchers working in many disciplines as well as the general public. In addition to an overview of the work currently ongoing, the authors critically assess these projects from an ethical and philosophical perspective. Key Features Provides an overview of nanomedicine Employs a reflective and coherent critical evaluation of the benefits and risks of nanomedicine Written in an accessible manner intended for a wide audience Related Titles Hehenberger, M. Nanomedicine: Science, Business, and impact (ISBN 978-9-8146-1376-7). Beg, S., et al. Nanomedicine for the treatment of Disease: From Concept to Application (ISBN 978-1-7746-3443-1) Brenner, S. The Clinical Nanomedicine Handbook (ISBN 978-1-1380-7578-8)
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Bertrand H. Rihn
Relationship A01
9 (RLIN) 779

No items available.